Regulatory News
Wednesday, November 9, 2016
UPDATE 1-Alexion says investigating Soliris sales practices
Nov 10 (Reuters) - Alexion Pharmaceuticals Inc said
on Wednesday it was investigating allegations made by a former
employee regarding sales practices involving its flagship and
costly blood disorder...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment